SCHEMBL7914878

SCHEMBL7914878

Oc1ccc(-c2ccc(-c3nnc(Nc4cccc(Cl)c4)c4ccccc34)cc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.79
ALDH1A1 P00352 2/20 0.79
KDM4E B2RXH2 1/20 0.79
PDE5A O76074 1/20 0.79
CYP1A2 P05177 1/20 0.79
CYP3A4 P08684 1/20 0.79
CYP2D6 P10635 1/20 0.79
CYP2C9 P11712 1/20 0.79
HPGD P15428 1/20 0.79
ALOX15 P16050 1/20 0.79
CYP2C19 P33261 1/20 0.79
PDE1A P54750 1/20 0.79
PDE1B Q01064 1/20 0.79
PDE3B Q13370 1/20 0.79
PDE1C Q14123 1/20 0.79
PDE3A Q14432 1/20 0.79
SMN1; SMN2 Q16637 1/20 0.79
HSD17B10 Q99714 1/20 0.79
NPSR1 Q6W5P4 2/20 0.77
KDR P35968 5/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7914877 0.89 MAPT (0.66) MAPTALDH1A1KDM4EPDE5ACYP1A2
SCHEMBL29478480 0.88 MAPT (1.00) MAPTALDH1A1KDM4EPDE5ACYP1A2
SCHEMBL29478484 0.88 MAPT (1.00) MAPTALDH1A1KDM4EPDE5ACYP1A2
SCHEMBL1752920 0.88 MAPT (1.00) MAPTALDH1A1KDM4EPDE5ACYP1A2
SCHEMBL7912100 0.86 MAPT (0.81) MAPTALDH1A1KDM4EPDE5ACYP1A2
SCHEMBL7913391 0.86 MAPT (0.81) MAPTALDH1A1KDM4EPDE5ACYP1A2
SCHEMBL7918565 0.84 KDR (0.81) MAPTALDH1A1KDM4EPDE5ACYP1A2
SCHEMBL7918570 0.84 NPSR1 (1.00) MAPTALDH1A1KDM4EPDE5ACYP1A2
Hydrochloric Acid SCHEMBL1831909 0.83 GAA (0.84) MAPTALDH1A1KDM4EPDE5ACYP1A2
SCHEMBL7918387 0.83 MAPT (0.75) MAPTALDH1A1KDM4EPDE5ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed